Finasteride nano-transferosomal gel formula for management of androgenetic alopecia: ex vivo investigational approach

INTRODUCTION: Finasteride (FIN) is known as type II 5α-reductase inhibitor, which has been approved for the treatment and prevention of androgenetic alopecia. Administration of FIN by oral route has led to undesirable systemic side effects that include mood disturbance, gynecomastia, decreased libid...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahmed, Osama AA, Rizq, Waleed Y
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6070339/
https://www.ncbi.nlm.nih.gov/pubmed/30104862
http://dx.doi.org/10.2147/DDDT.S171888

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6070339/
https://www.ncbi.nlm.nih.gov/pubmed/30104862
http://dx.doi.org/10.2147/DDDT.S171888

Ejemplares similares